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Summary 
Inhibition of natural killer (NK) cells by the killer cell inhibitory receptor (KIR) involves re- 
cruitment of the tyrosine phosphatase SHP-1 by KIR and is prevented by expression of a dom- 
inant negative SHP-1 mutant. Another inhibitory receptor, the low affinity Fc receptor for im- 
munoglobulin G  (IgG) (Fc',/Rllbl), has been shown to bind SHP-1 when cocross-hnked with 
the antigen receptor on B cells (BCR). However, cohgation of Fc'yRIIbl with BCR and with 
FceRI on mast cells leads to recruitment of the inositol 5' phosphatase SHIP and to inhibition 
of mast cells from SHP-l-deficient mice. In this study, we evaluated the ability of these two 
inhibitory receptors to block target cell lysis by NK cells, and the contribution of SHP-1 and 
SHIP to inhibition. Recombinant vaccinia viruses encoding chimeric receptors and dominant 
negative mutants of SHP-1 and SHIP were used for expression in mouse and human NK cells. 
When the KIR cytoplasmic tail was replaced by that of Fc~/RIIbl, recognition of HLA class I 
on target cells by the extracellular domain resulted in inhibition. A dominant negative mutant 
of SHP-1 reverted the inhibition mediated by the KIR cytoplasmic tail but not that mediated 
by Fc~/RIIbl.  In contrast, a dominant negative mutant of SHIP reverted only the inhibition 
mediated by the Fc~/RIIbl  tail,  providing functional evidence that SHIP plays  a role in the 
Fc~/RIIbl-mediated negative  signal.  These data  demonstrate that inhibition of NK  cells by 
KIR  involves  primarily  the  tyrosine  phosphatase  SHP-1,  whereas  inhibition  mediated  by 
Fc~/RIIbl requires the inositol phosphatase SHIP. 
A 
ctivation of different types of cells in the immune sys- 
tem  shares  common  signal  transduction  pathways, 
such as activation of tyrosine kinases,  turnover of phospho- 
inositides,  and  calcium  mobihzation.  The  description  of 
several inhibitory receptors that can interrupt the activation 
process in different cell types has  generated interest in the 
mechanism of inhibition and raised questions about features 
that may be shared by the different receptors. It has been 
proposed that  both  the  inhibitory Fc  receptor Fc'yRIIbl 
and the killer cell inhibitory receptor (KIR) mediate inhi- 
bition by recruitment  of the  SH2-containing protein ty- 
rosine phosphatase SHP-1 (1-6). However, it has also been 
shown that Fc~/RIIbl can inhibit mast cells that do not ex- 
press SHP-1  (7). The aim of this study was to compare the 
inhibition mediated by Fc'fRIIbl and KIR in the same cell 
type and to evaluate the contribution of SHP-1 and SH2- 
containing inositol polyphosphatase 5' phosphatase (SHIP) 
to these negative signals. 
Fc'fRllbl  inhibits  activation  responses  when  cocross- 
linked with the B cell, T  cell, and mast cell antigen recep- 
tots (8-10). The cytoplasmic tail of Fc'yRIIbl contains an 
immunoreceptor tyrosine-based inhibitory motif (ITIM), 
which is necessary for the inhibitory function of the recep- 
tor (9,  10).  In vitro, the phosphorylated Fc~/RIIbl  ITIM 
associates with SHP-1 and to a 145-kD protein designated 
as SHIP (7). SHIP is involved in inhibition of growth factor 
and cytokine responses  (11,  12).  Coligation of Fc'yRIIbl 
with the IgE receptor on bone marrow-derived mast cells 
from me~me mice, which lack SHP-1, still resulted in inhi- 
bition of degranulation (7), demonstrating that SHP-1 was 
not necessary for inhibition and suggesting  that SHIP might 
be involved in the negative signal  mediated by FcyRIIbl. 
However, no functional evidence has been obtained for a 
role of SHIP in the inhibition mediated by Fc~/RIIbl. 
The KIR expressed on human natural killer (NK)  cells 
deliver a negative signal  upon recognition of MHC class I 
molecules on target cells  (13,  14).  Tyrosine phosphoryla- 
tion of the ITIMs in the cytoplasmic tail of KIR is critical 
for recruitment of SHP-1 and for inhibition (2--6, 15). Ex- 
pression of a dominant negative mutant of SHP-1  in NK 
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an important role for SHP-1 in the negative signal (2). The 
possibility that SHIP may also be involved in the inhibition 
of NK cells mediated by KIR has not been investigated. To 
test rigorously whether KIR and Fc~/RIIbl can deliver in- 
hibitory signals in the same cell type through similar or dis- 
tinct  signaling pathways,  and  whether  SHIP  may be  in- 
volved in the KIR-mediated inhibition of NK cells, we have 
constructed chimeric KIR molecules with the cytoplasmic 
tail of Fc~/RIIbl  and  assessed their  ability to  inhibit  NK 
ceils.  We  report  here  that  SHIP,  but  not  SHP-1,  is  re- 
quired for the negative signal transmitted by Fc~/RIIbl and 
that the reverse is true for KIR. 
Materials  and Methods 
Cells and Antibodies.  The  human NK cell line NK92  (a gift 
from H.-G. Klingemann, The Terry Fox Laboratory, Vancouver, 
Canada) (16) was maintained in Myelocult H5100 medium (Stem 
Cell Technologies, Inc., Vancouver, Canada) and supplemented 
with  100  U/m1  rIL-2. The B  lymphoblastoid cell line 721.221 
and its HLA class I transfectants .221-Cw3 and .221-Cw4 were pro- 
vided by J.  Gumperz and P. Parham (Stanford University, Stan- 
ford, CA). Mouse NK populations were generated from C57BL/6 
mice as described (17). The anti-p58-KIR mAb GL183 (18) was 
provided by A. Moretta and C. Bottino (University of Genova, 
Italy) and anti-p58-KIR mAb EB6 was obtained from Immunotech, 
Inc. (Westbrook, ME). The FITC-conjugated F(ab')2 goat anti- 
mouse IgG was from Jackson Im~unoResearch (West Grove, PA). 
cDNAs and Construction of Chimeras.  The  chimeric  KIR-6/ 
RIIbl cDNA was constructed by ligation of fragments encoding 
the extracellular and transmembrane regions ofKIR-6 (a p58-KIR 
reactive with mAb GL183) with the cytoplasmic region of hu- 
man Fc'yRIIbl. The cytoplasmic tail of Fc'yRIIbl was amplified 
from a cDNA molecule containing the transmembrane and cyto- 
plasmic regions of  human Fc~/RIIbl (a gift fromJ. Altrichter, Na- 
tional Institute of Allergy and Infectious Diseases, Bethesda, MD) 
using the  forward primer 5'-TTGATCTACCTTAGGAAAAA 
GCGGATTTCAG-3'  containing a  Bsu36I  restriction site  and 
reverse primer 5'-TGCACCGAATTCAGACTAAATACGG-3' 
containing a stop codon followed by an EcoRI  restriction site. 
The  fragment encoding KIR-6 used for ligation was amplified 
from the plasmid pSPORT-p58-c16  (19),  using forward primer 
5'-AGCTCCCGGAGCTCCTATGACATG-3' containing a SacI 
site and the reverse primer 5'-GCAGCAGGATCCCCTAAG- 
GAGAAAGAAGAGGAG-3' containing  a  Bsu36I  site  and  a 
BamHI  site  for  cloning  into  pBluescript.  The  Bsu361-EcoRI 
fragment encoding the cytoplasmic tail of Fc"/RIIB1 was ligated 
to the Bsu36I-EcoRI digested pBluescript-cl6, followed by exci- 
sion of the SacI-EcoRV chimeric insert and subcloning into the 
SacI-StuI sites of pSPORT-cl6. The amino acids at the KIR-6/ 
Fc~/Rllbl boundary are FFLL/RKKR. Chimeric KIR-42/RIIb1 
was made by replacing the extracellular segment of KIR-6 be- 
tween  the  restriction sites  Sall-BstEII with  that  of KIR-42  (a 
p58-KIR reactive with mAb EB6).  The BstEII site encodes the 
amino acids glycine and asparagine that are five residues upstream 
from the start of the transmembrane region in both KIR-6 and 
KIR-42. A truncated version of KIR-6 was generated by ampli- 
fying a fragment of pSPORT-cl6 (from the initiation codon to 
asparagine 258  of KIR-6)  using  the  forward primer 5'-GTC- 
AAACTCGAGTGACCCAC-3' containing the  XhoI  site  and 
the  reverse  primer  5'-CTGTTCTCCCGGGTCATCCTTG- 
GTTGTCCATTACAACAGC-3' containing StyI site followed 
by a stop codon and a SmaI site. The XhoI-Smal fragment was 
then ligated back into the XhoI-StuI sites of pSPORT-cl6 such 
that the cytoplasmic tail is 17 amino acids long (the last three res- 
idues, asparagine, glutamine, and glycine were added before the 
stop codon during PCR  amplification) and lacks the two ITIM 
sequences.  The  truncated  KIR-6  (KIR-6tr)  and  the  chimeric 
constructs  KIR-6/RIIbl  and  KIR-42/RIIb1  were  subcloned 
into the plasmid pSC66 (gift of B. Moss, National Institute of Al- 
lergy and Infectious Diseases, Bethesda, MD) and used to gener- 
ate recombinant vaccinia viruses as described (20). 
Dominant Negative Mutants of SHP- 1 and SHIP.  A  recombinant 
vaccmia virus encoding a mutant form of SHP-1 with a point mu- 
tation in the catalytic site (cysteine 453  to serine) has been de- 
scribed (2). A cDNA encoding SHIP was used to make a deletion 
mutant containing the SH2 domain alone (referred to as SHIP- 
SH2) by PCR amplification from the start site to leucine 166 fol- 
lowed by a stop codon and a SalI site. The PCR fragment was 
cloned into  a  modified version of the  vaccinia vector pSC66, 
which contains at its NH  2 terminus an ATG initiation site in a 
suitable context,  a  Flag epitope (21),  and a  NotI  site in-frame 
with the coding sequence. 
Vaccinia Virus Infections.  Purified  viruses  encoding  KIR-6, 
KIR-6/RIIbl, KIR-6tr, KIR-42, KIR-42/RIIb1, SHP-1C453S, 
and SHIP-SH2 were used to infect mouse NK populations or the 
human cell line NK92 as described (14). 
Cytotoxicity Assays.  The  ability of mouse  NK  and  human 
NK92 cells to lyse targets was measured in a 4-h SlCr release assay 
as described (14). 
Results and Discussion 
To  test whether  the  cytoplasmic tail of Fc'yRIIbl may 
inhibit  NK  cells,  and  to  address  the  role  of the  tyrosine 
phosphatase  SHP-1  and  inositol phosphatase  SHIP in the 
negative signal delivered by these receptors, chimeric mol- 
ecules with the cytoplasmic tail of Fc~tRIIbl and the extra- 
cellular domains  of KIR-6  or  KIR-42  were  constructed 
(Fig.  1).  As  a  control,  a  truncated  version  of KIR-6  was 
made  (Fig.  1),  which lacks both  ITIM sequences  that are 
essential for KIR-mediated inhibition (4,  15). KIR-6 pre- 
vents the lysis of HLA-Cw3  positive target cells, whereas 
KIR-42  prevents  lysis  of targets  that  express  HLA-Cw4 
(14). Recombinant vaccinia viruses were made that express 
the chimeric KIR-6/RIIbl,  KIR-42/RIIbl,  and KIR-6tr 
molecules. 
Expression of KIR-6 on mouse NK cells inhibits the an- 
tibody-dependent cell-mediated cytotoxicity of HLA-Cw3 
positive .221  targets (15).  NKI.1 +,  TCR-  NK cells, pre- 
pared  from  the  spleens  of C57B1/6  mice  were  infected 
with Vac-6, Vac-6/RIIbl, and Vac-6tr and tested for their 
ability to lyse .221  and .221-Cw3  target cells. The infected 
cells  expressed  comparable  levels  of the  three  receptors 
(Fig.  2  A).  NK  cells expressing KIR-6/RIIbl  lysed .221 
cells but had reduced  cytotoxic activity against .221-Cw3 
ceils. Uninfected cells and those infected with Vac-6tr lysed 
both .221 and .221-Cw3 to the same extent (Fig. 2 B). Thus, 
the  cytoplasmic tail of Fc~RIIbl  can deliver a  signal that 
inhibits the cytotoxic function of NK cells. 
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Figure  1.  Schematic representation of the chimeric receptors. Hybrid 
molecules bearing the cytoplasmic  tail of  human Fc3,RIIbl and the extra- 
cellular domains of KIR-cI6 or KIR-cI42 were generated as described. 
Open, hatched, and shaded boxes represent sequences from KIR-6, KIR- 
42, and Fc~/RIIbl, respectively. Closed boxes represent transmembrane 
regions and open bars in the cytoplasmic  tails indicate the position oflTIMs. 
Expression of a catalytically inactive mutant of SHP-1 in 
human NK cells reverts the KIR-mediated inhibition oft 
get cell lysis (2, 6). KIR-6, KIR-42, and their chimeric coun- 
terparts  KIR-6/RIIbl  and KIR-42/RIIb1 were expressed 
in the human NK cell line NK92 either individually or to- 
gether with the dominant negative mutant of SHP-1.  The 
surface staining of  Vac-6 and Vac-6/RIIbl infected cells by 
GL183 and that of  Vac-42 and Vac-42/RIIbl infected cells 
by EB6 was comparable as seen by the mean fluorescence 
intensities  (Fig. 3).  Coinfection of NK92 cells  with the re- 
ceptors along with dominant negative SHP-1  did not alter 
their  surface  expression  (Fig.  3).  NK92  cells infected with 
Vac-6 or with Vac-6/RIIbl killed .221  and .221-Cw4 tar- 
gets but were inhibited from lysing .221-Cw3 targets.  Re- 
ciprocally,  cells  infected  with  Vac-42  and  Vac-42/RIIbl 
lysed  .221  and  .221-Cw3  but  not  .221-Cw4  targets  (Fig. 
3).  Therefore,  as shown in mouse  NK cells,  the  cytoplas- 
mic tail of Fc~/RIIbl was able to deliver an inhibitory sig- 
nal  in  human  NK  cells.  Expression  of dominant  negative 
SHP-1  in NK92 reverted the KIR-mediated inhibition  of 
target cell lysis but not that mediated by the cytoplasmic tail 
of Fc~/RIIbl  (Fig. 3).  Thus, SHP-1  appears to play an im- 
portant role in KIR-mediated inhibition of NK cells,  as re- 
ported earlier (2), but not in Fc~/RIIbl-mediated inhibition 
of NK cells. 
A  recent report showed that mast cells  from SHP-l-defi- 
cient me~me mice are inhibited by FcyRIIbl (7).  Cocluster- 
ing Fc',/RIIbl with the BCR or FceRI led to recruitment of 
SHIP, suggesting that SHIP is involved in inhibition mediated 
by Fc~/RIIbl (7).  We tested functionally whether SHIP has 
a  role  in  Fc'yRIIbl-mediated  inhibition  and  whether  it 
may  also  contribute  to  KIR-mediated  inhibition  of NK 
cells. KIR or chimeric KIR. were expressed in NK92 cells to- 
gether with a dominant negative mutant of SHIP contain- 
ing  the  SH2  domain  alone.  Expression  of SHIP-SH2  in 
NK92 caused some reduction in the ability of NK92 to lyse 
target cells,  as well as a small reduction in the expression of 
KIR  during  coinfections  (Fig.  4).  The  partial  inhibition 
mediated by KIR-6 when NK92 were tested with .221-Cw4 
cells  has  not been  consistently  observed.  Coexpression  of 
SHIP-SH2 prevented  the  inhibition  mediated by KIR-6/ 
0  •  |  , 
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Figure 2.  The cytoplasmic  tail of human Fc'yRIIbl can dehver an in- 
hibitory signal in mouse NK cells. (A) Surface  expression ofKIR-6, KIR- 
6/RIIbl, and KIR-6tr on cells infected with 5, 5, and 10 PFU/cell of  the 
indicated recombinant vaccinia viruses, respectively. (B) Specific lysis of 
the B cell line .221 (open circles), and its HLA-Cw3 transfectant (closed dr- 
des) by uninfected mouse NK cells or those infected with Vac-6, Vac-6/ 
RIIbl or Vac-6tr. ADCC was induced by precoating the targets with 0.1 
I*g/rnl of anti-HLA-DR mAb L243 for 30 re.in on ice. Effectors and tar- 
gets were plated at the indicated ratios. 
RIIbl and KIR-42/RIIb1 but not that mediated by KIR-6 
or by KIR-42 (Fig. 4). 
These data provide functional evidence that SHIP is re- 
quired  for the  negative  signal  delivered  by  Fc~/RIIbl.  In 
addition, they demonstrate that two distinct signaling path- 
ways can turn  off the  cytotoxic activity of NK cells  upon 
interaction  with  target  cells.  The  inhibitory receptor  nor- 
mally used by human NK cells to detect self-MHC  class  I 
on target cells  requires  interaction with the tyrosine phos- 
phatase  SHP-1  to  deliver  the  inhibitory  signal  (2,  6).  In 
contrast, Fc'yRIIbl, whose function is to inhibit B  cell and 
mast cell activation in the presence of soluble IgG, requires 
the  inositol  phosphatase  SHIP to  inhibit  NK  cells.  KIR 
signaling interferes  with  early  activation  events,  including 
tyrosine phosphorylation of FcR-associated ~ chain,  ZAP- 
70, and PLC-',/2 (6),  and calcium flux (22, 23). KIR recog- 
nition of HLA class I on target cells was also found to pre- 
vent association of the adaptor protein pp36 with PLC-yl 
(23). The lack of a role for SHIP in KIR-mediated inhibi- 
tion  is  consistent  with  the  identification  of SHP-1  as  the 
only major protein  purified from lysates of T, B,  and NK 
cells by phosphopeptides corresponding to the KIR ITIMs 
immobilized  on beads  (24).  In contrast,  a  phosphopeptide 
corresponding to the ITIM of Fc'yRIIbl precipitated both 
SHP-1  and SHIP from such cell lysates (24). However, the 
functional evidence provided here indicates that association 
of Fc~/RIIbl with SHP-1  is not necessary for inhibition of 
NK cells. 
Stimulation  of B  cells by receptor cross-linking involves 
rapid  release  of Ca  2+  from  intracellular  stores  and  a  sus- 
tained influx of extracellular calcium (25). A significant fea- 
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Figure  3.  SHP-1  is  not  required  for  inhibition  of NK  cells  by 
Fc~RIIbl. The KIK-negative human NK92 cell hne was infected with 
recombinant vaccinia viruses expressing KIR-6, KIR-42, or their chi- 
meric derivatives bearing the cytoplasmic tail of human Fc~/Rllb  I (KIR- 
6/RIIbl and KIR-42/RIIb1), alone or with dominant negative SHP-1 
(dnSHP-1), as indicated. The mean fluorescence intensity of  staining with 
mAbs GL183 (for KIR-6 and KIR-6/RIIbl) and EB6 (for KIR-42 and 
KIR-42/RIIbl) is indicated next to each bar in the .221 panel. Lysis of 
.221, .221-Cw3, and .221-Cw4 targets was determined in a 4-h slCr re- 
lease assay at an E/T of 4. Similar results were observed at an E/T of 1 
and in two independent experiments. 
ture  of Fc',/RIIbl-mediated inhibition is a  s61ective block 
in calcium influx through the plasma membrane while not 
affecting release from  intracellular stores  (7,  26,  27).  The 
enzymatic  activities  of SHIP  include  removal  of the  5' 
phosphate moiety from substrates like phosphatidylinositol 
3,4,5-trisphosphate  (PIP3)  and inositol 1,3,4,5-tetrakisphos- 
phate (IP4) (11,  12). Therefore, downstream events depen- 
dent on these phosphoinositol metabolites are likely to be 
inhibited by SHIP (28). Maximal tyrosine phosphorylation 
of SHIP and association with  Shc  was  observed in B  cells 
upon cocross-linking of the BCR with Fc'yILIIbl (29).  Thus, 
SHIP association with the Fc~/RIIbl ITIM could sequester 
Shc and uncouple the early tyrosine phosphorylation events 
from late events like p21 ~  activation (30). 
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Figure 4.  SHIP is required for inhibition of NK cells by Fc~/Rllbl but 
not by KIR.. The experiment was as described in Fig. 3 except that a 
dominant negative SHIP (dnSHIP) was used. The data shown were ob- 
tained at an E/T of 6. Similar results were obtained at an E/T of 1 and in 
two independent experiments. 
The evolution of distinct mechanisms to block lympho- 
cyte activation may relate to the consequences of partial ac- 
tivation of various  types of lymphocytes.  Cocross-linking 
of surface Ig with Fc~/RIIbl results in accelerated entry into 
apoptosis by B  cells as compared with that caused by cross- 
linking surface Ig alone (31). The function of Fc'yRIIbl is to 
inhibit Ig-producing and proliferating B  cells after soluble 
Ig has been produced. Therefore,  apoptosis may be useful 
to eliminate these cells. The function of KIR is to protect 
normal cells from attack by NK cells. Therefore, it is essen- 
tial for KIR to provide a  complete and reliable shutdown 
of the NK cell. The most suited target in this inhibitory path- 
way would be  tyrosine-phosphorylated substrates that  are 
proximal in the activation pathway. Recruitment of SHP-1 
by KIR followed by rapid dephosphorylation of proximal 
substrates  may  fulfill this  requirement.  Thus,  the  dichot- 
omy in the use of SHP-1 by KIR and SHIP by Fc',/RIIbl, 
as  demonstrated  by  our  data,  appears  well  suited  to  the 
function of the cells in which these receptors operate. 
The authors wish to thank M. Weston for technical assistance, J. Altrichter for helpful discussions and a plas- 
mid, H.-G. Klingemann for the cell line NK92, B. Moss for the plasmid pSC66, A. Moretta and C. Bottino 
for the mAb GL183,  andJ. Gumperz and P. Parham for the 721.221  HLA transfectants. 
Address correspondence to E.O. Long, LIG-NIAID-NIH Twinbrook II, 12441 Parldawn Drive, R.ockxflle, 
MD 20852-1727. E-mail: elong@nih.gov 
Received  for pubtication 2 May 1997. 
476  Negative Signals of the Killer Cell Inhibitory Keceptor and Fc',/Pdlbl References 
1.  D'Ambrosio, D.,  K.L.  Hippen, S.A. Minskoff, I. Mellman, 
G.  Pani,  K.A.  Siminovitch, and J.C.  Cambier.  1995.  Re- 
cruitment and activation of PTP1C in negative regulation of 
antigen receptor signaling by Fc'yRIIB1. Science (Wash.  DC). 
268:293-297. 
2.  Burshtyn, D.N., A.M. Scharenberg, N. Wagtmann, S. Raja- 
gopalan, K. Berrada, T. Yi, J.P. Kinet, and E.O. Long. 1996. 
Recruitment of tyrosine phosphatase HCP by the killer cell 
inhibitor receptor. Immunity.  4:77-85. 
3.  Olcese, L., P. Long, F. V6ly, A. Cambiaggi, D. Marguet, M. 
Bl6ry,  K.L.  Hippen,  R.  Biassoni, A. Moretta,  L.  Moretto, 
J.C. Cambier, and E. Vivier. 1996. Human and mouse killer- 
cell inhibitory receptors recruit PTPIC and PTP1D  protein 
tyrosine phosphatases.J. Immunol.  156:4531-4534. 
4.  Fry,  A.M.,  L.L.  Lanier,  and  A.  Weiss.  1996.  Phosphoty- 
rosines in the killer cell inhibitory receptor motif of NKB1 
are required for negative signaling and for association with 
protein tyrosine phosphatase 1C.J. Exp. Med.  184:295-300. 
5.  Campbell, K.S., M. Dessing, M. Lopez-Botet, M. Cella, and 
M.  Colonna.  1996.  Tyrosine phosphorylation of a  human 
killer inhibitory receptor recruits protein tyrosine phospha- 
tase 1C.J. Exp. Med.  184:93-100. 
6.  Binstadt, B.A., K.M. Brumbaugh, C.J. Dick, A.M. Scharen- 
berg,  B.L.  Williams, M.  Colonna,  L.L.  Lanier, J.P.  Kinet, 
R.T. Abraham, and p.J. Leibson.  1996.  Sequential involve- 
ment oflck and SHP-1 with MHC-recognizing receptors on 
NK cells inhibits FcR-initiated tyrosine kinase activation. Im- 
munity.  5:629-638. 
7.  Ono,  M.,  S.  Bolland, P.  Tempst,  and J.V.  Ravetch.  1996. 
Role of the inositol phosphatase SHIP in negative regulation 
of the  immune  system  by  the  receptor  Fc'¥RIIB.  Nature 
(Lond.). 383:263-266. 
8.  Amigorena, S.,  C.  Bonnerot, J.R.  Drake,  D.  Choquet,  W. 
Hunziker, J.G.  GuiUet, P.  Webster, C.  Sautes, I. Mellman, 
and W.H. Fridman. 1992.  Cytoplasmic domain heterogene- 
ity and functions of IgG Fc receptors in B lymphocytes. Sci- 
ence (Wash.  DC). 256:1808-1812. 
9.  Muta,  T.,  T.  Kurosaki,  Z.  Misulovin,  M.  Sanchez,  M.C. 
Nussenzweig, andJ.V. Ravetch. 1994. A  13-amino-acid mo- 
tif in the cytoplasmic domain of Fc~/RIIB modulates B-cell 
receptor signalling. Nature (Lond.). 368:70-73. 
10. Daeron, M., S. Latour, O. Malbec, E. Espinosa, P. Pina, S. 
Pasmans,  and W.H. Fridman. 1995. The same tyrosine-based 
inhibition motif, in the intracytoplasmic domain of Fc~/RIIB, 
regulates negatively BCR-,  TCR-, and FcR-dependent cell 
activation. Immunity.  3:635-646. 
11. Damen, J.E., L. Liu, P. Rosten, R.K. Humphries, A.B. Jef- 
ferson,  P.W.  Majerus,  and G.  Krystal.  1996.  The  145-kDa 
protein induced to associate with Shc by multiple cytokines 
is an inositol tetraphosphate and phosphatidylinositol 3,4,5- 
triphosphate 5-phosphatase. Proc. Natl.  Acad. Sci. USA.  93: 
1689-I693. 
12. Lioubin, M.N., P.A. Algate, S. Tsai, K. Carlberg, R. Aeber- 
sold, and L.R. Rohrschneider.  1996. p150Ship, a signal trans- 
duction  molecule  with  inositol polyphosphate-5-phospha- 
tase activity. Genes Dev. 10:1084-1095. 
13. Moretta, A., M.  Vitale, C. Bottino, A.M.  Orengo, L. Mo- 
relli, R. Augugliaro, M. Barbaresi, E. Ciccone, and L. Mor- 
etta. 1993.  P58 molecules as putative receptors for major his- 
tocompatibility complex (MHC)  class I molecules in human 
natural killer (NK) cells. Anti-p58 antibodies reconstitute lysis 
of MHC class I-protected cells in NK clones displaying dif- 
ferent specificities.J. Exp. Med.  178:597-604. 
14. Wagtmann,  N.,  S.  Rajagopalan, C.C.  Winter,  M.  Pemzzi, 
and E.O. Long. 1995.  Killer cell inhibitory receptors specific 
for HLA-C and HLA-B identified by direct binding and by 
functional transfer. Immunity.  3:801-809. 
15. Rojo,  S.,  D.N.  Burshtyn,  E.O.  Long,  and  N.  Wagtmann. 
1997.  Type I transmembrane receptor with inhibitory func- 
tion in mouse mast cells and NK cells.J. Immunol.  158:9-12. 
16. Gong, J.H., G. Maki, and H.G. Klingemann. 1994.  Charac- 
terization of a human  cell line  (NK-92)  with phenotypical 
and functional characteristics of activated natural killer cells. 
Leukemia. 8:652-658. 
17. Karlhofer, F.M. and W.M. Yokoyama. 1991.  Stimulation of 
murine natural killer (NK)  cells by a monoclonal antibody 
specific for the NKI.1 antigen. IL-2-activated NK cells pos- 
sess additional specific stimulation pathways. J. Immunol.  146: 
3662-3673. 
18. Moretta, A., G. Tambussi, C. Bottino, G. Tripodi, A_ Merli, 
E. Ciccone, G. Pantaleo, and L. Moretta. 1990. A novel sur- 
face antigen expressed by a subset of human CD3-  CD16+ 
natural killer cells.  Role in cell activation and regulation of 
cytolytic function.J. Exp. Med.  171:695-714. 
19. Wagtmann,  N.,  R.  Biassoni, C.  Cantoni,  S.  Verdiani,  M. 
Malnati, M. Vitate, C. Bottino, L. Moretta, A. Moretta, and 
E.O. Long.  1995.  Molecular clones of the p58 natural killer 
cell  receptor  reveal  Ig-related molecules with  diversity in 
both the extra- and intracellular  domains. Immunity. 2:439-449. 
20. Earl,  P.L.,  and B.  Moss.  1988.  Generation of recombinant 
vaccinia viruses. In Current Protocols in Molecular Biology. 
F.M. Ausubel, R. Brent, R.E.  Kingston, D.D. Moore, J.G. 
Seidman, J.A. Smith, and K. Stmhl, editors. John Wiley & 
Sons, New York. 16.17.1-16.17.16. 
21. Hopp,  T.P.,  K.S.  Prickett,  V.L.  Price,  R.T.  Libby,  C.J. 
March, D.P. Cerretti, D.L. Urdal, and P.J.  Conlon. 1988.  A 
short polypeptide marker sequence for recombinant protein 
identification and purification. Biotechnology. 6:1204-1210. 
22. Kaufman, D.S., R.A. Schoon, M.J. Robertson, and P.J. Leib- 
son.  1995.  Inhibition of selective signaling events in natural 
killer cells recognizing major histocompatibility  complex class 
I. Proc. Natl. Acad. Sci. USA. 92:6484-6488. 
23. Valiante, N.M., J.H.  Phillips, L.L.  Lanier,  and  P.  Parham. 
1996.  Killer cell inhibitory receptor recognition of human 
leukocyte antigen (HLA) class I blocks formation of a pp36/ 
PLC-~ signaling complex in human natural killer (NK) cells. 
J. Exp. Med.  184:2243-2250. 
24. Burshtyn, D.N., W. Yang, T. Yi, and E.O.  Long.  1997.  A 
novel phosphotyrosine motif with a critical amino acid at po- 
sition -2 for the SH2 domain-mediated activation of the ty- 
rosine phosphatase SHP-1. J. Biol. Chem. 272:13066-13072. 
25.  Cambier, J.C., C.M. Pleiman, and M.R. Clark. 1994.  Signal 
transduction by the B  cell antigen receptor and its corecep- 
tors. Annu. Rev. Immunol.  12:457--486. 
26. Choquet,  D.,  M.  Partiseti,  S.  Amigorena,  C.  Bonnerot, 
W.H. Fridman, and H. Korn. 1993.  Cross-linking oflgG re- 
ceptors inhibits membrane  immunoglobulin-stimulated cal- 
cium influx in B lymphocytes.J. Cell Biol. 121:355-363. 
27. Diegel, M.L., B.M.  Rankin, J.B.  Bolen,  P.M.  Dubois,  and 
P.A. Kiener.  1994.  Cross-linking of Fc  3,  receptor to surface 
immunoglobulin on B cells provides an inhibitory signal that 
closes the plasma membrane calcium channel. J. Biol. Chem. 
269:11409-11416. 
28. Scharenberg, A.M., andJ.P. Kinet. 1996.  The emerging field 
477  Gupta et al.  Brief  Definitive Report of receptor-mediated  inhibitory  signaling:  SHP  or  SHIP? 
Cell. 87:961-964. 
29.  Chacko,  G.W.,  S.  Tridandapani,  J.E.  Damen,  L.  Liu,  G. 
Krystal, and K.M. Coggeshall.  1996. Negative signaling in B 
lymphocytes induces  tyrosine phosphorylation of the  145- 
kDa inositol polyphosphate 5-phosphatase,  SHIP.J. Immunot. 
157:2234-2238. 
30.  Sarmay, G., G. Koncz, andJ. Gergely. 1996. Human type II 
Fc7 receptors inhibit B cell activation by interacting with the 
p21ras-dependent pathway.J. Biol.  Chem. 271:30499-30504. 
31. Ashman, R.F., D. Peckham, and L.L. Stunz.  1996. Fc recep- 
tor off-signal in the B cell involves apoptosis.J. Immunol.  157: 
5-11. 
478  Negative Signals of  the Killer Cell Inhibitory Receptor and Fc~/Rllbl 